By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genetic testing firm Gene Security Network has received a $2 million grant from the National Institutes of Health to conduct a clinical trial for its non-invasive prenatal diagnosis (NIPD) technology.

GSN will use the funding to conduct a randomized clinical trial for its Parental Support NIPD test. The research phase of the clinical study has already begun, and the prospective trial is scheduled to start later this year, the Redwood, Calif.-based company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.